Monir Sadat Hakemi

526 total citations
32 papers, 348 citations indexed

About

Monir Sadat Hakemi is a scholar working on Nephrology, Surgery and Transplantation. According to data from OpenAlex, Monir Sadat Hakemi has authored 32 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 9 papers in Surgery and 8 papers in Transplantation. Recurrent topics in Monir Sadat Hakemi's work include Renal Transplantation Outcomes and Treatments (8 papers), Dialysis and Renal Disease Management (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Monir Sadat Hakemi is often cited by papers focused on Renal Transplantation Outcomes and Treatments (8 papers), Dialysis and Renal Disease Management (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Monir Sadat Hakemi collaborates with scholars based in Iran and United States. Monir Sadat Hakemi's co-authors include Amir Ahmad Nassiri, Iraj Najafi, Behrooz Broumand, Ali Haghighi, Mehdi Rambod, Fereidoun Azizi, Mir Mohammad Miri, Ali‐Akbar Nejatisafa, Babak Bahar and Fatemeh Attari and has published in prestigious journals such as PLoS ONE, Transplantation and Trials.

In The Last Decade

Monir Sadat Hakemi

29 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monir Sadat Hakemi Iran 12 98 79 72 57 43 32 348
Faissal A M Shaheen Saudi Arabia 11 101 1.0× 193 2.4× 86 1.2× 32 0.6× 31 0.7× 43 417
Scott Reule United States 12 116 1.2× 171 2.2× 76 1.1× 105 1.8× 43 1.0× 28 470
Golara Zahmatkesh United States 7 47 0.5× 136 1.7× 89 1.2× 44 0.8× 48 1.1× 8 319
Donna I. Myers United States 6 103 1.1× 122 1.5× 41 0.6× 35 0.6× 77 1.8× 7 332
Gamal Saadi Egypt 11 50 0.5× 218 2.8× 55 0.8× 29 0.5× 22 0.5× 72 501
Bülent Erbay Türkiye 11 140 1.4× 97 1.2× 78 1.1× 40 0.7× 52 1.2× 24 565
Shahrzad Ossareh Iran 13 104 1.1× 269 3.4× 109 1.5× 106 1.9× 69 1.6× 55 564
John S. Thurlow United States 4 56 0.6× 283 3.6× 74 1.0× 101 1.8× 36 0.8× 9 500
G Yakupoğlu Türkiye 13 162 1.7× 142 1.8× 158 2.2× 52 0.9× 120 2.8× 39 570
Amir Ahmad Nassiri Iran 10 57 0.6× 111 1.4× 58 0.8× 60 1.1× 8 0.2× 25 340

Countries citing papers authored by Monir Sadat Hakemi

Since Specialization
Citations

This map shows the geographic impact of Monir Sadat Hakemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monir Sadat Hakemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monir Sadat Hakemi more than expected).

Fields of papers citing papers by Monir Sadat Hakemi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monir Sadat Hakemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monir Sadat Hakemi. The network helps show where Monir Sadat Hakemi may publish in the future.

Co-authorship network of co-authors of Monir Sadat Hakemi

This figure shows the co-authorship network connecting the top 25 collaborators of Monir Sadat Hakemi. A scholar is included among the top collaborators of Monir Sadat Hakemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monir Sadat Hakemi. Monir Sadat Hakemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sadeghi, Sara, Amir Ahmad Nassiri, Monir Sadat Hakemi, et al.. (2025). Effects of melatonin supplementation on oxidative stress, and inflammatory biomarkers in diabetic patients with chronic kidney disease: a double-blind, randomized controlled trial. BMC Nutrition. 11(1). 34–34. 1 indexed citations
3.
Mansour, Asieh, et al.. (2024). Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome. BMC Endocrine Disorders. 24(1). 201–201. 10 indexed citations
5.
Nassiri, Amir Ahmad, et al.. (2023). The Renal Histopathological Findings in Patients with Renal Allograft Dysfunction: A Retrospective Single Center Study.. PubMed. 17(3). 168–173. 1 indexed citations
6.
Hakemi, Monir Sadat, et al.. (2022). Benefit of Hemoadsorption Therapy in Patients Suffering Sepsis-Associated Acute Kidney Injury: A Case Series. Blood Purification. 51(10). 823–830. 9 indexed citations
8.
Imani, Hossein, et al.. (2020). The effect of vitamin E supplementation on biomarkers of endothelial function and inflammation among hemodialysis patients: A double-blinded randomized clinical trial. Complementary Therapies in Medicine. 49. 102357–102357. 14 indexed citations
9.
Asgari, Samaneh, Fereidoun Azizi, Hengameh Abdi, et al.. (2020). Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study. Global Heart. 15(1). 29–29. 19 indexed citations
10.
Sepanlou, Sadaf G, Iraj Najafi, Farin Kamangar, et al.. (2017). Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study. PLoS ONE. 12(5). e0176540–e0176540. 39 indexed citations
11.
Hakemi, Monir Sadat. (2014). Chronic kidney disease epidemiology.. PubMed. 8(4). 261–2. 17 indexed citations
12.
Nassiri, Amir Ahmad & Monir Sadat Hakemi. (2013). Serum magnesium level and cardiovascular disease in dialysis patients.. PubMed. 7(1). 2–4. 7 indexed citations
13.
Hakemi, Monir Sadat, Iraj Najafi, Amir Ahmad Nassiri, et al.. (2012). Association of Overtime Urine Volume and Ultrafiltration Changes with Patient Survival in Continuous Ambulatory Peritoneal Dialysis Patients. Renal Failure. 34(10). 1223–1228. 1 indexed citations
14.
Hakemi, Monir Sadat, et al.. (2009). Chronic Kidney Disease After Hematopoietic Cell Transplantation: Frequency, Risk Factors, and Outcomes. Transplantation Proceedings. 41(7). 2895–2897. 15 indexed citations
15.
Nejatisafa, Ali‐Akbar, et al.. (2008). Quality of Life and Life Events of Living Unrelated Kidney Donors in Iran: A Multicenter Study. Transplantation. 86(7). 937–940. 35 indexed citations
16.
Hakemi, Monir Sadat, et al.. (2007). Association of Hyperglycemia on Allograft Function in the Early Period After Renal Transplantation. Transplantation Proceedings. 39(4). 852–854. 23 indexed citations
17.
Hakemi, Monir Sadat, et al.. (2007). Socioeconomic Status of Iranian Living Unrelated Kidney Donors: A Multicenter Study. Transplantation Proceedings. 39(4). 824–825. 38 indexed citations
18.
Hakemi, Monir Sadat, et al.. (2003). Impact of hepatitis C virus infection on short-term outcome in renal transplantation: a single-center study. Transplantation Proceedings. 35(7). 2699–2700. 5 indexed citations
19.
Hakemi, Monir Sadat, et al.. (2002). Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience). Transplantation Proceedings. 34(6). 2091–2092. 3 indexed citations
20.
Hakemi, Monir Sadat, et al.. (2001). Peripheral blood microchimerism in female renal recipients from male donors. Transplantation Proceedings. 33(5). 2852–2853. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026